FDA Recall Completed Historical recordClass II
Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,115
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,793
Class I recallsReasonable probability of serious health consequences24,343
Class II recallsTemporary or medically reversible health consequences2,887
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/so-delicious-dairy-freer-issues-voluntary-recall-salted-caramel-cluster-non-dairy-frozen-dessertPublished September 15, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears XP Clear Emollient Lubricant Gel Drops Moderate Sterile, 1/3 FL OZ (10 mL), Mfd. By: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-143-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears TF Clear Emollient Lubricant Gel Drops Tear Film Replenishment Mild Sterile, 0.5 FL OZ (15 mL), Manufactured by: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-142-13
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Nano Tears TF Clear Emollient Lubricant Gel Drops Twin Pack, Product Size: 2 x 15 mL, Mfd. By: by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-142-49
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Nano Tears TF Clear Emollient Lubricant Gel Drops Preservative Free, Product Size: 0.6 mL x 32 ct., Mfd. By: by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-141-56
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears MXP Forte Clear Emollient Lubricant Gel Drops Preservative Free, Product Size: 0.6 mL x 32 ct, Mfd. By: by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-147-56
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears TF Clear Emollient Lubricant Gel Drops Preservative Free Multi-Dose Mild Dry Eye Therapy, 0.25 FL OZ (7.5 mL), Mfd. By: by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-141-52
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears MXP Forte Clear Emollient Lubricant Gel Drops, 10 mL, Mfd. By: by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-144-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions Nano Tears MO Clear Emollient Lubricant Drops Intensive Sterile, 10 mL, Manufactured by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390- 145-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
iSolutions NanoTears HA Preservative Free Multi - Dose Lubricant Gel Drops Sterile, 0.33 FL OZ (10 mL), Manufactured by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-208-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Goniotaire Hypromellose 2.5% Opthlamic Demulcent Solution (Sterile), 1/2 fl oz 15 mL, Mfd. by: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-182-13
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Sterile Eye Wash, 118 mL (4 fl oz), Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-175-35
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Sterile Eye Wash, 30 mL (1 fl oz.), Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-175-18
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Fluorescein Sodium with Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.25%/0.5%, 5 mL (Sterile), Rx only, Manufactured by Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-205-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Diclofenac Sodium Opthalmic Solution, 0.1%, 2.5 mL, Rx only, Manufactured Altaire Pharmaceuticals, NDC 59390-149-02
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, 10 mL, Rx only, Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931 NDC 59390-217-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 NDC 59390-217-02
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
ActivEyes Sterile Altalube Ointment, Net Wt 1/8 oz (3.5g), NDC 59390-198-50
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
ActivEyes Altachlore Solution, 15 mL (1/2 FL OZ), Manufactured by Altaire Pharmaceuticals Inc., Aquebogue, NY 11931, NDC 59390-183-13
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
FDA Recall Completed Historical recordClass II
ActivEyes Altachlore Sodium Chloride Hypertonicity Opthalmic Ointment, 5%, Manufactured by: Altaire Pharmaceuticals Inc. Aquebogue, NY 11931, NDC 59390-184-50
- Reason
- Lack of Assurance of Sterility
- Published
- November 27, 2019
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
